Back

In vivo KCNH2-suppression-replacement gene therapy attenuates the pathogenic phenotype in transgenic rabbits with short QT syndrome type 1

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award Basic and Translational Science Ion Channels, Electrophysiology EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Saranda Nimani

University of Bern, Bern (Switzerland)

4 More presentations in this session

Presentation thumbnail
Accelerated pacing reduces left heart filling pressures: a novel therapy for heart failure with preserved ejection fraction?
Mr T. Van Loon (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
The right atrium affects in silico arrhythmia vulnerability in both atria
Ms P. Martinez Diaz (Karlsruhe, DE)
Abstract Slides Video
Presentation thumbnail
Revealing intracavitary catheter positions: artificial intelligence-enhanced localization with an electrogram-driven variational autoencoder model
Mr G. Rios-Munoz (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Reduced heart failure hospitalizations and improved quality of life in cardiac amyloidosis patients undergoing atrial fibrillation ablation
Doctor N. Pierucci (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award Basic and Translational Science
Video

The Event

Event poster

EHRA 2024

7 April - 9 April 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources